Australian & New Zealand Childrens Haematology/Oncology Group

Clinical Trials

Viewing: Clinical Trials

Filter by

Neuroblastoma

Status: Open | NSW , VIC , WA

LINES: European Low and Intermediate Risk Neuroblastoma (Phase III SIOPEN study)

Brain tumours

Status: Temporarily closed to accrual | NSW , QLD , TAS , VIC , WA , SA , New Zealand

MNP2.0: Molecular Neuropathology 2.0

NF-1 associated plexiform neurofibromas or progressive optic pathway gliomas

Status: Preparing to Open

TINT: A phase II study of trametinib in paediatric, adolescent and young adult patients with Neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas.

Rhabdomyosarcoma

Status: Preparing to Open

Far-RMS: Frontline and Relapse Study in RhabdomyoSarcoma Study

Hypermutant Cancers

Status: Open | NSW , QLD , SA

Hypermutant Cancers Trial: A Pilot Study of Nivolumab in Paediatric Patients with Hypermutant Cancers

Brain cancer: Medulloblastoma

Status: Open | QLD , VIC , WA

SJ ELiOT: Phase 1 Evaluation of LY2606368, a CHK inhibitor, in combination with cyclophosphamide or gemcitabine for children & adolescents with recurrent medulloblastoma tumours.

All posts loaded.

All posts loaded.

Load more trials